All Type of News
Antispasmodic Drugs Under Restrictive Watch by KFDA
The Korea Food and Drug Administration (KFDA) announced that it would restrict approval, production and sale of seven drugs containing noraminopyrine methane sulfonate calcium (NMSC), which has an antispasmodic effect...
Dong-A’s Management Change Not Likely to Affect Its Stock Price
From a recent announcement surrounding the key management change by Dong-A Pharmaceuticals, the market is viewing this as a positive momentum for the company, reported Kim Hee-sung, an analyst at HanYang Securities.
...
Pharmacies Could Receive Tax Benefits from Courtesy Expense Reporting
Pharmacies could utilize a number of items subject to tax benefits as they prepare their tax returns for the year-end, recommended by the pharmacy tax specialists. Such benefits could be derived from reporting items ...
Johnson & Johnson Korea Forms Alliance with Local Wholesaler
Johnson & Johnson Korea announced that the company has made a collaborative alliance agreement with Dongwon Pharmaceuticals, a domestic pharmaceutical wholesale company, to supply Johnson & Johnson’s blood glucose mon...
COX-2 Inhibitor Found To Help Prevent Gastric Cancer
The Korea Food and Drug Administration (KFDA) announced December 3rd on its discovery of additional efficacy of COX-2 (cyclooxygenase-2) inhibitor, which is a type of non-steroidal anti-inflammatory drugs (NSAIDs) for...
Redundancy Found in Original Drug Identification Label
The pharmaceutical companies expressed their concerns and difficulties in conforming to an upcoming regulation regarding each company’s original drug identification label requirement effective January 1, 2005.
On...
DMF Implementation Postponed by 8 Months
The Drug Review Division under the Korean Food and Drug Administration (KFDA) announced it will postpone an implementation of the Pharmaceutical Bulk Report System by eight months, suggesting that the Drug Master File...
More Pharmaceutical Companies’ CEOs from R&D, Production Backgrounds
The trend amongst the domestic pharmaceutical companies to promote their production and R&D managers to chief executive officer positions has been observed.
Ever since the separation of dispensary from medical pra...
Future Medical Cost by Individuals Will Significantly Increase
The National Health Insurance Corporation (NHIC) recently released its comparative analysis on the domestic health insurance key indices and characteristics as compared to other OECD countries.
Based on the above...
Serious Side Effects by Isotretinoin Re-Emphasized by KFDA
The Korea Food and Drug Administration (KFDA) re-emphasized on the serious side effects associated with isotretinoin, which is used for treatment of acne, in its December 3rd ‘Dear Healthcare Professional Letter’ addr...
